SUMO-specific protease 2 is essential for modulating p53-mdm2 in development of trophoblast stem cell niches and lineages

PLoS Biology

Volumn 6, Issue 12, 2008, Pages 2801-2816

  Chiu, Shang Yi ^a   Asai, Naoya ^b,c   Costantini, Frank ^c   Hsu, Wei ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NAGOYA UNIVERSITY   (Japan)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; PROTEIN P53; PROTEINASE; SUMO PROTEIN; SUMO SPECIFIC PROTEASE 2; UNCLASSIFIED DRUG; CYSTEINE PROTEINASE; MDM2 PROTEIN, MOUSE; MULTIENZYME COMPLEX; SENP2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDOREDUPLICATION; MITOSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLACENTA DEVELOPMENT; PROTEIN EXPRESSION; REPRODUCTION; SUMOYLATION; TROPHOBLAST; ANIMAL; ANIMAL EMBRYO; CELL CYCLE; DRUG EFFECT; METABOLISM; PHYSIOLOGY; PRENATAL DEVELOPMENT;

MAMMALIA; MUS;

ANIMALS; CELL CYCLE; CELL LINEAGE; CYSTEINE ENDOPEPTIDASES; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; MICE; MULTIENZYME COMPLEXES; PROTO-ONCOGENE PROTEINS C-MDM2; TROPHOBLASTS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 58149175974     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.0060310     Document Type: Article

References (58)

1. Rossant J, Cross JC (2001) Placental development: lessons from mouse mutants. Nat Rev Genet 2: 538-548.
2. Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, et al. (2004) Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 114: 744-754.
3. Simmons DG, Cross JC (2005) Determinants of trophoblast lineage and cell subtype specification in the mouse placenta. Dev Biol 284: 12-24.
4. Armant DR (2005) Blastocysts don't go it alone. Extrinsic signals fine-tune the intrinsic developmental programof trophoblast cells. Dev Biol 280: 260-280.
5. Sutherland A (2003) Mechanisms of implantation in the mouse: differentiation and functional importance of trophoblast giant cell behavior. Dev Biol 258: 241-251.
6. Mossman HW (1991) Classics revisited: comparative morphogenesis of the fetal membranes and accessory uterine structures. Placenta 12: 1-5.
7. Cross JC, Simmons DG, Watson ED (2003) Chorioallantoic morphogenesis and formation of the placental villous tree. Ann N Y Acad Sci 995: 84-93.
8. Cross JC, Nakano H, Natale DR, Simmons DG, Watson ED (2006) Branching morphogenesis during development of placental villi. Differentiation 74: 393-401.
9. Melchior F (2000) SUMO-nonclassical ubiquitin. Annu Rev Cell Dev Biol 16: 591-626.
10. Schwartz DC, Hochstrasser M (2003) A superfamily of protein tags: ubiquitin, SUMO and related modifiers. Trends Biochem Sci 28: 321-328.
11. Seeler JS, Dejean A (2003) Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol 4: 690-699.
12. Muller S, Ledl A, Schmidt D (2004) SUMO: a regulator of gene expression and genome integrity. Oncogene 23: 1998-2008.
13. Mahajan R, Delphin C, Guan T, Gerace L, Melchior F (1997) A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88: 97-107.
14. Kadoya T, Kishida S, Fukui A, Hinoi T, Michiue T, et al. (2000) Inhibition of Wnt signaling pathway by a novel axin-binding protein. J Biol Chem 275: 37030-37037.
15. Best JL, Ganiatsas S, Agarwal S, Changou A, Salomoni P, et al. (2002) SUMO-1 protease-1 regulates gene transcription through PML. Mol Cell 10: 843-855.
16. Nishida T, Kaneko F, Kitagawa M, Yasuda H (2001) Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat axam, which is an axin-binding protein promoting beta-catenin degradation. J Biol Chem 276: 39060-39066.
17. Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, et al. (1997) The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90: 181-192.
18. Yu HM, Jerchow B, Sheu TJ, Liu B, Costantini F, et al. (2005) The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development 132: 1995-2005.
19. Tanaka H, Nagaike K, Takeda N, Itoh H, Kohama K, et al. (2005) Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta. Mol Cell Biol 25: 5687-5698.
20. Beck F, Erler T, Russell A, James R (1995) Expression of Cdx-2 in the mouse embryo and placenta: possible role in patterning of the extra-embryonic membranes. Dev Dyn 204: 219-227.
21. Anson-Cartwright L, Dawson K, Holmyard D, Fisher SJ, Lazzarini RA, et al. (2000) The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat Genet 25: 311-314.
22. Simmons DG, Fortier AL, Cross JC (2007) Diverse subtypes and developmental origins of trophoblast giant cells in the mouse placenta. Dev Biol 304: 567-578.
23. Ishida M, Ono K, Taguchi S, Ohashi S, Naito J, et al. (2004) Cathepsin gene expression in mouse placenta during the latter half of pregnancy. J Reprod Dev 50: 515-523.
24. Miner JH, Cunningham J, Sanes JR (1998) Roles for laminin in embryogenesis: exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain. J Cell Biol 143: 1713-1723.
25. Yamamoto T, Roby KF, Kwok SC, Soares MJ (1994) Transcriptional activation of cytochrome P450 side chain cleavage enzyme expression during trophoblast cell differentiation. J Biol Chem 269: 6517-6523.
26. Riley P, Anson-Cartwright L, Cross JC (1998) The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis. Nat Genet 18: 271-275.
27. Palmieri SL, Peter W, Hess H, Scholer HR (1994) Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev Biol 166: 259-267.
28. Worman HJ, Yuan J, Blobel G, Georgatos SD (1988) A lamin B receptor in the nuclear envelope. Proc Natl Acad Sci U S A 85: 8531-8534.
29. MacAuley A, Cross JC, Werb Z (1998) Reprogramming the cell cycle for endoreduplication in rodent trophoblast cells. Mol Biol Cell 9: 795-807.
30. Tanaka S, Kunath T, Hadjantonakis AK, Nagy A, Rossant J (1998) Promotion of trophoblast stem cell proliferation by FGF4. Science 282: 2072-2075.
31. Yamamoto H, Ihara M, Matsuura Y, Kikuchi A (2003) Sumoylation is involved in beta-catenin-dependent activation of Tcf-4. EMBO J 22: 2047-2059.
32. Mudgett JS, Ding J, Guh-Siesel L, Chartrain NA, Yang L, et al. (2000) Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci U S A 97: 10454-10459.
33. Hatano N, Mori Y, Oh-hora M, Kosugi A, Fujikawa T, et al. (2003) Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 8: 847-856.
34. Giroux S, Tremblay M, Bernard D, Cardin-Girard JF, Aubry S, et al. (1999) Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr Biol 9: 369-372.
35. Galabova-Kovacs G, Matzen D, Piazzolla D, Meissl K, Plyushch T, et al. (2006) Essential role of B-Raf in ERK activation during extraembryonic development. Proc Natl Acad Sci U S A 103: 1325-1330.
36. Rui HL, Fan E, Zhou HM, Xu Z, Zhang Y, et al. (2002) SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling. J Biol Chem 277: 42981-42986.
37. Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53- mediated transactivation. Cell 69: 1237-1245.
38. Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299.
39. Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303.
40. Honda R, Tanaka H, Yasuda H (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420: 25-27.
41. Parisi T, Beck AR, Rougier N, McNeil T, Lucian L, et al. (2003) Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO J 22: 4794-4803.
42. Komatsu D, Abe T, Sano Y, Shimazaki K, Tomita M, et al. (2007) Increase of the trophoblast giant cells with prolactin-releasing peptide (PrRP) receptor expression in p53-null mice. Mol Reprod Dev 74: 1089-1094.
43. Storchova Z, Pellman D (2004) From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 5: 45-54.
44. Minn AJ, Boise LH, Thompson CB (1996) Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev 10: 2621-2631.
45. Lanni JS, Jacks T (1998) Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 18: 1055-1064.
46. Andreassen PR, Lohez OD, Lacroix FB, Margolis RL (2001) Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell 12: 1315-1328.
47. Meek DW, Knippschild U (2003) Posttranslational modification of MDM2. Mol Cancer Res 1: 1017-1026.
48. Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, et al. (2000) Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J 19: 6185-6195.
49. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, et al. (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406: 207-210.
50. Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, et al. (1999) Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 18: 6462-6471.
51. Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, et al. (1999) SUMO-1 modification activates the transcriptional response of p53. EMBO J 18: 6455-6461.
52. Yu HM, Liu B, Chiu SY, Costantini F, Hsu W (2005) Development of a unique system for spatiotemporal and lineage-specific gene expression in mice. Proc Natl Acad Sci U S A 102: 8615-8620.
53. Liu B, Yu HM, Hsu W (2007) Craniosynostosis caused by Axin2 deficiency is mediated through distinct functions of beta-catenin in proliferation and differentiation. Dev Biol 301: 298-308.
54. Hsu W, Zeng L, Costantini F (1999) Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain. J Biol Chem 274: 3439-3445.
55. Chen J, Marechal V, Levine AJ (1993) Mapping of the p53 and mdm-2 interaction domains. Mol Cell Biol 13: 4107-4114.
56. Scott IC, Anson-Cartwright L, Riley P, Reda D, Cross JC (2000) The HAND1 basic helix-loop-helix transcription factor regulates trophoblast differentiation via multiple mechanisms. Mol Cell Biol 20: 530-541.
57. Yu HM, Liu B, Costantini F, Hsu W (2007) Impaired neural development caused by inducible expression of Axin in transgenic mice. Mech Dev 124: 146-156.
58. Hsu W, Shakya R, Costantini F (2001) Impaired mammary gland and lymphoid development caused by inducible expression of Axin in transgenic mice. J Cell Biol 155: 1055-1064.